Akoya Biosciences, Inc. (AKYA)
NASDAQ: AKYA · IEX Real-Time Price · USD
2.180
-0.030 (-1.36%)
At close: Jul 2, 2024, 4:00 PM
2.250
+0.070 (3.21%)
After-hours: Jul 2, 2024, 5:01 PM EDT
Akoya Biosciences Market Cap
Akoya Biosciences has a market cap or net worth of $107.66 million as of July 2, 2024. Its market cap has decreased by -59.72% in one year.
Market Cap
107.66M
Enterprise Value
130.57M
1-Year Change
-59.72%
Ranking
Category
Stock Price
$2.18
Market Cap Chart
Since the IPO on April 16, 2021, Akoya Biosciences's market cap has decreased from $713.79M to $107.66M, a decrease of -84.92%. That is a compound annual growth rate of -44.52%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 1, 2024 | 109.10M | -54.45% |
| Dec 29, 2023 | 239.50M | -34.06% |
| Dec 30, 2022 | 363.20M | -36.25% |
| Dec 31, 2021 | 569.70M | -20.19% |
View and export this data all the way back to 2021.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| G1 Therapeutics | 119.20M |
| Assertio Holdings | 117.95M |
| Regulus Therapeutics | 116.86M |
| Nuvectis Pharma | 116.19M |
| TELA Bio | 115.88M |
| Omega Therapeutics | 114.17M |
| Corvus Pharmaceuticals | 113.84M |
| Journey Medical | 112.87M |